{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:18:44Z","timestamp":1783581524468,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":306,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes Research"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aim of this study is to evaluate the real\u2010world prescribing patterns of SGLT2 inhibitors and GLP\u20101 receptor agonists (GLP\u20101RA) in patients with newly diagnosed Type 2 diabetes (T2DM), particularly among those with high cardiovascular risks or chronic kidney disease, and to identify demographic, clinical, and system\u2010level factors associated with receiving these medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>This cross\u2010sectional study analyzed electronic medical records (EMRs) of patients with newly diagnosed T2DM from 60 primary care clinics in West Michigan between April 2021 and January 2023. We assessed the documented prescription rates of SGLT2 inhibitors and GLP\u20101RAs within 3 months of diagnosis based on EMRs, particularly in high\u2010risk subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 19.9% of\n                      <jats:italic>n<\/jats:italic>\n                      = 5783 patients with newly diagnosed T2DM had either an SGLT2 inhibitor or GLP\u20101RA prescribed. Prescription rates for these agents were 20.0% for patients with chronic ischemic heart disease and 19.3% for those with impaired kidney function. In adjusted analyses, higher BMI (aOR 2.92 for BMI &gt; 40\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , 95% CI 1.58\u20135.42, ref BMI &lt; 24\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), hyperlipidemia (aOR 1.89, 95% CI 1.28\u20132.79), chronic ischemic heart disease (aOR 1.55, 95% CI 1.11\u20132.18), and higher HbA1c (aOR 1.32 per 1% increase, 95% CI 1.22\u20131.42) were associated with higher odds of receiving prescription of these medications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite guideline recommendations, SGLT2 inhibitors and GLP\u20101RAs are prescribed to only a minority of patients with newly diagnosed T2DM, even among those with clear indications. Efforts to improve guideline\u2010adherent care in primary care settings are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/jdr\/6656982","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:50:37Z","timestamp":1762239037000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SGLT2 Inhibitor and GLP\u20101 Receptor Agonist Prescriptions in Newly Diagnosed Type 2 Diabetes Patients With Cardiorenal Risks: A Cross\u2010Sectional Study"],"prefix":"10.1155","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9496-9423","authenticated-orcid":false,"given":"Frank","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Bouthillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-0245","authenticated-orcid":false,"given":"Omayma","family":"Alshaarawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Azhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-9193","authenticated-orcid":false,"given":"Harland T.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"e_1_2_12_1_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01163-9"},{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0033"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S009"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz486"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.037"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0013"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/ds19-0019"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14684"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009099"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.20969"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-024-08961-x"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0383"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05962-z"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2016.01.008"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.107394"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0260-x"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13304"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad082"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S011"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S010"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0353-9"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15473"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14987"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.13885"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1815"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.3839"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2020.88554"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2023.0531"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q28"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p2019"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1693"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.2337\/cd23-0023"},{"key":"e_1_2_12_36_2","unstructured":"History of Formulary Changes-Post-Single PDL Changes (After October 1 2020). Michigan Department of Health and Human Services; 2024 accessed August 4 2024 https:\/\/www.michigan.gov\/mdhhs\/-\/media\/Project\/Websites\/mdhhs\/Assistance-Programs\/Medicaid-BPHASA\/History-of-Formulary-Changes-for-web_Post-Single-PDL.pdf."},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.30.1.34"}],"container-title":["Journal of Diabetes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/jdr\/6656982","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/jdr\/6656982","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/jdr\/6656982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:49:56Z","timestamp":1773780596000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/jdr\/6656982"}},"subtitle":[],"editor":[{"given":"Ilaria","family":"Campesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1155\/jdr\/6656982"],"URL":"https:\/\/doi.org\/10.1155\/jdr\/6656982","archive":["Portico"],"relation":{},"ISSN":["2314-6745","2314-6753"],"issn-type":[{"value":"2314-6745","type":"print"},{"value":"2314-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2025-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"6656982"}}